![Alexey Vinogradov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexey Vinogradov
Director/Board Member at
XENETIC BIOSCIENCES, INC.
Net worth: 47 351 $ as of 2026-07-30
Profile
Alexey Andreevich Vinogradov is Director at Pharmsynthez PJSC since 2023.
Director at Avelas Biosciences, Inc. since 2017.
Independent Non-Executive Director at Xenetic Biosciences, Inc. since 2019.
Director-Operations & Business Development at Cantreva LLC since 2017.
Formerly Independent Director at Argos Therapeutics, Inc. from 2014 to 2016.
Investment Manager at Bioprocess Capital Partners Ltd. in 2010.
Managing Partner at Pharmstandard Ventures.
General Manager at Togas Middle East LLC from 2015 to 2017.
Branch Manager at Togas Group LLC from 2012 to 2016.
Education includes a doctorate from Moscow State University Lomonosov.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 18,679 ( 0.82% ) | 47 351 $ | 2026-07-30 |
Alexey Vinogradov active positions
| Companies | Position | Start |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Director/Board Member | 2019-07-18 |
| PHARMSYNTHEZ | Director/Board Member | 2023-08-02 |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Director/Board Member | 2017-03-13 |
Cantreva LLC | Chief Operating Officer | 2017-08-31 |
Former positions of Alexey Vinogradov
| Companies | Position | End |
|---|---|---|
Togas Middle East LLC | Corporate Officer/Principal | 2017-04-30 |
Togas Group LLC | Corporate Officer/Principal | 2016-10-31 |
| ARGOS THERAPEUTICS, INC. | Director/Board Member | 2016-06-09 |
Bioprocess Capital Partners Ltd.
 Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 2010-12-30 |
Pharmstandard Ventures
 Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Chief Executive Officer | - |
Training of Alexey Vinogradov
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmsynthez PJSC
 Pharmsynthez PJSC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Finance |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Cantreva LLC | |
Togas Middle East LLC | |
Togas Group LLC |
- Stock Market
- Insiders
- Alexey Vinogradov
